Beneficiary details: Wojciech Winkel
Wojciech Winkel
Is a beneficiary in 17 companies
Entries in the Central Register of Beneficial Owners shows that Wojciech Winkel is a beneficiary in 17 companies.
Tamtech
Ul. Bukowska 332, Pl-60-189, Poznań
Company age 2 years 8 months
Holds 97.50% shares in a company with a total amount of 195 000 zł
More »
Maredo
Ul. Bukowska 332, Pl-60-189, Poznań
Company age 2 years 7 months 23 days
Holds 97.50% shares in a company with a total amount of 195 000 zł
More »
Diagnopol
Opolska 159, Pl-52-013, Wrocław
Company age 16 years 1 month 26 days
Holds 50.00% shares in a company with a total amount of 5 000 zł
More »
Dargorol
Ul. Marcelińska 92, Pl-60-324, Poznań
Company age 12 years 7 months 25 days
Holds 95.00% shares in a company with a total amount of 4 750 zł
More »
Strzelecko kolekcjonerskie muszkieterowie
Ul. Odrzycka 17A, Pl-60-186, Poznań
Company age 8 years 9 months 19 days
świt spółka z ograniczoną odpowiedzialnością
Irysowa 15, Pl-52-200, Wysoka
Company age 8 years 1 month 15 days
Holds 25.00% shares in a company with a total amount of 1 000 zł
More »
Moderna group
Ul. Bukowska 332, Pl-60-189, Poznań
Company age 2 years 2 months 30 days
Holds 100.00% shares in a company with a total amount of 100 000 zł
More »
Matilda group
Ul. Bukowska 332, Pl-60-189, Poznań
Company age 5 months 14 days
Holds 100.00% shares in a company with a total amount of 50 000 zł
More »
A beneficiary is an individual or entity that receives benefits, such as financial resources, grants, or other assistance, typically as a result of an agreement or program. Beneficiaries can be individuals, organizations, businesses, or public institutions. In the context of EU or government programs, a beneficiary must meet specific criteria to be eligible for support.
Beneficiary of companies
Wojciech Winkel
Tamtech
Tempus infrastruktura
Fortium
Maredo
Tech-net
Diagnopol
Tempus telecom
Dargorol
Tempus.net
Tempus leasing
Strzelecko kolekcjonerskie muszkieterowie
świt spółka z ograniczoną odpowiedzialnością
Moderna group
Matilda group
Nextia development
Kdw rest
Pharmacy research institute